Skip to main content
Figure 3 | Journal of Hematology & Oncology

Figure 3

From: Local administration of a novel Toll-like receptor 7 agonist in combination with doxorubicin induces durable tumouricidal effects in a murine model of T cell lymphoma

Figure 3

Treatment schedule and survival curve. (A) The left cartoon shows the administration methods of the drugs in each treatment group (listed in the right table). (B) The schematic diagram indicated the course schedule, in which the SZU-101 was administered daily from day 1 to day 5, and DOX was administered on days 1, 3 and 5. (C) The survival curve indicates 60-day survival post treatment of the tumour-bearing mice with different treatments. Each treatment group in the experiment contained at least nine mice.

Back to article page